For instance, in 2017, Medtech Startup Axio Biosolutions announced the positive results for the clinical trial of axiostat dental haemostatic dressing in patients on oral antiplatelet drugs. The study ...

Axiostat, a 100% chitosan haemostatic dressing to stop external bleeding, was earlier approved with CE mark in Europe. The FDA clearance now allows Axiostat to be marketed in the US as over-the ...

A workable innovative idea is a hallway to success. Leo Mavely, the young founder and Chief Executive of Bengaluru-based Axio Biosolutions, hit upon his Eureka moment about a deca ...

This 100% chitosan haemostatic dressing controls severe haemorrhage within minutes through its active adhesion to the trauma wound. The award winning and CE approved, Axiostat will be launched in ...